October 13, 2017 Auditory Biophysics Laboratory: Dr. Mai Elfarnawany's article on visualizing the middle ear using synchrotron radiation phase-contrast imaging (SR-PCI) made the cover of the journal Hearing Research.
September 14, 2017 Stryker's Mobile Lab was at University Hospital on September 6th, 2017. Trainees and consultants from the Department of Otolaryngology took part in a T-bone course sponsored by Stryker inside their one of a kind M.O.R.E. (Mobile Operating Room Experience) Lab.
February 09, 2017 Peng You (PGY2) won the best overall presentation for the Division of Paediatric Surgery 2nd Annual Research Day for his talk "Improving learning and confidence through structured otoscopy teaching - A prospective interventional study".
February 03, 2017 Financial accountability, cost savings and streamlining are very familiar terms for hospitals in Ontario. Publically funded health care organizations constantly have to find savings wherever possible. And as hospitals tighten their belts they depend on bright ideas from staff and physicians. Surgeons Dr. Leigh Sowerby and Brian Rotenberg with St. Joseph’s Otolaryngology Head and Neck Surgery Program, found savings not only in equipment costs but also in time.
January 19, 2017 Hanif Ladak has partnered with MED-EL, a company that develops cochlear implants, on yet another project. “One of the challenges with cochlear implants is programming the implant after surgery,” explained Ladak. “We are using imaging to assist with development of programming methodology to optimize hearing outcomes,” he added. The University’s strength in Otolaryngology and imaging make it a natural leader in this research area.
May 20, 2016 Collaboration between healthcare providers from different fields is essential for optimal patient care. Interprofessional teamwork is linked not only to improved patient outcomes, but also to decreased healthcare costs and a more efficient and effective working environment for healthcare providers.
August 03, 2015 Dr. Anthony Nichols has received $515,090 for his research on head and neck cancer. The disease and its treatment can have a profound negative impact on patient quality of life in terms of speech, the ability to eat, facial disfigurement and pain. Only one half of patients with advanced disease survive making the need to develop more effective and less toxic therapies important. PI3K inhibitors are a class of drug that have shown promise in treating a variety of cancers. Dr. Nichols research will focus on identifying the genetic changes involved in cancer cells to determine which tumours are susceptible to these drugs and how drug resistance can be prevented.
January 09, 2015 It isn't commonly known, but head and neck cancers have quietly become the second fastest growing form of the disease in North America.
In an effort to combat this problem, the men and women behind the Manuary Campaign are preparing for the 5th annual London event, in which the Head and Neck Surgery Department at London Health Sciences Centre (LHSC) aims to raise $25,000 to support ongoing research.